Dongxu Liu

A novel bispecific antibody targeting tumor necrosis factor α and ED-B fibronectin effectively inhibits the progression of established collagen-induce arthritis.

Lu-jun Li, Mengyuan Liu, M. Xie, 2014, Journal of biotechnology.

[Biologics for targeting inflammatory cytokines and their clinical application].

Jin Chen, Lu-jun Li, Mengyuan Liu, 2019, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

Exosome-based targeted RNA delivery for immune tolerance induction in skin transplantation.

Fenghua Wang, B. Wu, Fengjie Guo, 2020, Journal of biomedical materials research. Part A.

Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion

Yi Huang, Lei Hu, Mengyuan Liu, 2012, BMC Biotechnology.

Construction of Aptamer‐siRNA Chimera/PEI/5‐FU/Carbon Nanotube/Collagen Membranes for the Treatment of Peritoneal Dissemination of Drug‐Resistant Gastric Cancer

Zai-lin Yang, Sainan Yang, Xia Wei, 2020, Advanced healthcare materials.

The Inhibitory Effect of Regulatory T Cells on the Intimal Hyperplasia of Tissue-Engineered Blood Vessels in Diabetic Pigs

Wen Chen, Z. Ren, Fengjie Guo, 2022, Frontiers in Bioengineering and Biotechnology.

Differentiated expressed miRNAs in splenic monocyte induced by burn injury in mice.

Q. Su, Qing-Hong Zhang, Dongxu Liu, 2023, International wound journal.